Phathom Pharmaceuticals
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $74,274 | $58,301 | $57,584 | $49,504 |
Gross Profit | 59,178 | 46,305 | 49,936 | 43,314 |
EBITDA | -2,365 | -14,462 | -4,601 | -13,709 |
EBIT | -2,479 | -14,572 | -4,729 | -13,865 |
Net Income | -17,582 | -30,369 | -21,148 | -29,973 |
Net Change In Cash | 74,274 | 58,301 | 57,584 | 49,504 |
Free Cash Flow | -1,974 | -15,708 | -4,886 | -14,142 |
Cash | 182,478 | 180,904 | 129,972 | 135,156 |
Basic Shares | 83,747 | 82,050 | 73,817 | 73,396 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $175,110 | $55,252 | $682 | $0 |
Gross Profit | 152,511 | 47,279 | 515 | -620 |
EBITDA | -152,499 | -261,522 | -159,049 | -169,798 |
EBIT | -153,132 | -262,317 | -159,624 | -170,418 |
Net Income | -221,247 | -334,326 | -201,592 | -197,723 |
Net Change In Cash | 175,110 | 55,252 | 682 | 0 |
Free Cash Flow | -166,775 | -266,905 | -139,214 | -147,571 |
Cash | 129,972 | 297,263 | 381,393 | 155,385 |
Basic Shares | 72,918 | 63,176 | 51,289 | 39,118 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.08 |
2026-03-31 | -$0.18 |
2025-12-31 | -$0.16 |
2025-09-30 | -$0.15 |